Press Releases Ypsomed Group
Burgdorf – Ypsomed focuses on selling its own products.
In addition to the B2B Delivery Systems business with pens and autoinjectors, Ypsomed is to focus in future more on sales of its in-house developed pump systems and pen needles as well as on products marketed under the mylife Diabetescare brand. In this regard, the Ypsomed Group is planning to sell the German company DiaExpert which trades mainly third-party diabetes products.
